The role of ALOX5AP, LTA4H and LTB4R polymorphisms in determining baseline lung function and COPD susceptibility in UK smokers

[1]  David M. Evans,et al.  A Comprehensive Evaluation of Potential Lung Function Associated Genes in the SpiroMeta General Population Sample , 2011, PloS one.

[2]  A. Gaggar,et al.  A Critical Role for LTA4H in Limiting Chronic Pulmonary Neutrophilic Inflammation , 2010, Science.

[3]  Y. Liu,et al.  Modulating the Substrate Specificity of LTA4H Aminopeptidase by Using Chemical Compounds and Small‐Molecule‐Guided Mutagenesis , 2010, Chembiochem : a European journal of chemical biology.

[4]  D. Postma,et al.  Genes In The 5-lipoxygenase (5-LO) Pathway : Association With COPD , 2010, ATS 2010.

[5]  David M. Tobin,et al.  The lta4h Locus Modulates Susceptibility to Mycobacterial Infection in Zebrafish and Humans , 2010, Cell.

[6]  I. Sayers,et al.  PLAUR polymorphisms and lung function in UK smokers , 2009, BMC Medical Genetics.

[7]  D. Mannino,et al.  The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. , 2009, American journal of respiratory and critical care medicine.

[8]  I. Sayers,et al.  Leukotriene pathway genetics and pharmacogenetics in allergy , 2009, Allergy.

[9]  I. Sayers,et al.  The role of LTA4H and ALOX5AP polymorphism in asthma and allergy susceptibility , 2008, Allergy.

[10]  Yi Wang,et al.  BMC Medical Genetics , 2007 .

[11]  W. Calhoun,et al.  The role of leukotrienes in airway inflammation. , 2006, The Journal of allergy and clinical immunology.

[12]  I. Sayers,et al.  The cysteinyl‐leukotriene type 1 receptor polymorphism 927T/C is associated with atopy severity but not with asthma , 2006, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[13]  A. Kraneveld,et al.  A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation , 2006, Nature Medicine.

[14]  Vilmundur Gudnason,et al.  A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction , 2006, Nature Genetics.

[15]  Konstantinos Kostikas,et al.  Leukotriene B4 in exhaled breath condensate and sputum supernatant in patients with COPD and asthma. , 2005, Chest.

[16]  S. Kleeberger,et al.  Gene-environment interactions in asthma and other respiratory diseases. , 2005, Annual review of medicine.

[17]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[18]  Deborah A Meyers,et al.  Genetics of asthma and COPD. Similar results for different phenotypes. , 2004, Chest.

[19]  W. MacNee,et al.  Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper , 2004, European Respiratory Journal.

[20]  J. Gulcher,et al.  The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke , 2004, Nature Genetics.

[21]  P. Barnes,et al.  New concepts in chronic obstructive pulmonary disease. , 2003, Annual review of medicine.

[22]  I. Sayers,et al.  Promoter polymorphism in the 5‐lipoxygenase (ALOX5) and 5‐lipoxygenase‐activating protein (ALOX5AP) genes and asthma susceptibility in a Caucasian population , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[23]  I. Sayers,et al.  Promoter polymorphism influences the effect of dexamethasone on transcriptional activation of the LTC4 synthase gene , 2003, European Journal of Human Genetics.

[24]  P. Montuschi,et al.  CT-guided pleural biopsy preferable to traditional Abram’s needle in diagnosing malignant pleural disease , 2003, Thorax.

[25]  I. Sayers,et al.  Inhaled corticosteroids and long acting β2 agonists can help patients with COPD , 2003, Thorax.

[26]  R. Stockley,et al.  Sputum chemotactic activity in chronic obstructive pulmonary disease: effect of α1–antitrypsin deficiency and the role of leukotriene B4 and interleukin 8 , 2002, Thorax.

[27]  I. Sayers,et al.  Variant LTC4 synthase allele modifies cysteinyl leukotriene synthesis in eosinophils and predicts clinical response to zafirlukast , 2000, Thorax.

[28]  K. Kubo,et al.  Smoke extract stimulates lung fibroblasts to release neutrophil and monocyte chemotactic activities. , 1999, The American journal of physiology.

[29]  P. Devillier,et al.  Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part I: synthesis, receptors and role of leukotrienes in asthma. , 1999, Pharmacological research.

[30]  P. Barnes,et al.  Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. , 1996, American journal of respiratory and critical care medicine.

[31]  J. Evans,et al.  Cloning and characterization of the human leukotriene A4 hydrolase gene. , 1995, European journal of biochemistry.

[32]  A. Wardlaw,et al.  Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects. , 1992, Blood.

[33]  M. A. Bray,et al.  Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes , 1980, Nature.